FDA Grants Priority Review to Sanofi's Tolebrutini...
Category : Clinical Trial Update 26 March 2025The US Food and Drug Administration (FDA) is evaluating under priority review the regulatory submiss...
Clinical Trial Update
Clearmind’s FDA-Approved CMND-100 Trial Moves Forw...
Category : Clinical Trial Update 26 March 2025Clearmind Medicine Inc, a clinical-stage biotech company focused on discovery and development of nov...
Tempero Bio Starts Phase 2 Trial with TMP-301 for...
Category : Clinical Trial Update 25 March 2025Nxera Pharma Co., Ltd. announces that its partner Tempero Bio, Inc. has initiated a Phase 2 trial of...
Pharming Doses First Patient in Phase II Trial of...
Category : Clinical Trial Update 24 March 2025Pharming Group NV, a global biopharmaceutical company dedicated to transforming the lives of patient...
FRUSICA-2 Trial Meets Primary Endpoint for RCC in...
Category : Clinical Trial Update 20 March 2025Innovent Biologics, Inc, a world-class biopharmaceutical company that develops, manufactures and com...
Latest Newsletter Post
-
China NMPA grants breakthrough ther..
2 April 2025
-
Akums Unveils Ripasudil+timolol Com..
2 April 2025
-
Pfizer’s Abrysvo Wins EU Approval t..
2 April 2025
-
IASO Bio Secures NDA Approval on Eq..
29 March 2025
-
US FDA grants fast track designatio..
29 March 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com